X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - DRUGS.COM - Pharma Industry News - 12/Sep 15:09

Perioperative Nivolumab Beneficial for Resectable NSCLC

THURSDAY, Sept. 12, 2024 -- For patients with resectable non-small-cell lung cancer (NSCLC), perioperative nivolumab is associated with event-free survival (EFS) benefit compared with neoadjuvant nivolumab, according to a study presented at the...

Articles similaires

Sorry! Image not available at this time

WCLC 2024: Perioperative nivolumab may provide meaningful improvement in event-free survival compared to only neoadjuvant nivolumab plus chemotherapy for resectable NSCLC

oncologynews.com.au - 13/Sep 02:23

New data from landmark analysis presented today report a decreased risk of disease recurrence or death in patients with resectable NSCLC who received...

Sorry! Image not available at this time

Tusamitamab Ravtansine Does Not Extend Survival With Nonsquamous NSCLC

drugs.com - 13/Sep 14:09

FRIDAY, Sept. 13, 2024 -- Tusamitamab ravtansine (tusa rav), an immunoconjugate, does not improve progression-free survival (PFS) in patients with...

Sorry! Image not available at this time

Early, Virtual Palliative Care Feasible for Advanced Lung Cancer

drugs.com - 15:09

TUESDAY, Sept. 17, 2024 -- The delivery of early, virtual palliative care has similar effects on quality of life as in-person care in patients with...

Sorry! Image not available at this time

Doxorubicin + Trabectedin Tied to Increased Survival in Metastatic Leiomyosarcoma

drugs.com - 05/Sep 22:39

THURSDAY, Sept. 5, 2024 -- For patients with metastatic or surgically unresectable leiomyosarcoma, combination therapy with doxorubicin and...

Sorry! Image not available at this time

Long-Course Chemoradiotherapy Preferred TNT Regimen for Rectal Cancer

drugs.com - 12/Sep 21:31

THURSDAY, Sept. 12, 2024 -- For patients with locally advanced rectal cancer pursuing organ preservation, long-course chemoradiotherapy (LCCRT) is...

Sorry! Image not available at this time

Long-Course Chemoradiotherapy Preferred TNT Regimen for Rectal Cancer

drugs.com - 12/Sep 21:31

THURSDAY, Sept. 12, 2024 -- For patients with locally advanced rectal cancer pursuing organ preservation, long-course chemoradiotherapy (LCCRT) is...

Sorry! Image not available at this time

WCLC 2024: NeoCOAST-2 Data shows combination of Durvalumab with novel agents increases pathological responses in resectable NSCLC — Data builds on AEGEAN study research

oncologynews.com.au - 15/Sep 05:24

Phase 2 results from the NeoCOAST-2 study demonstrated that the combination of durvalumab with Dato-DXd yielded the highest pathological complete...

Sorry! Image not available at this time

WCLC 2024: NeoCOAST-2 Data shows combination of durvalumab with novel agents increases pathological responses in resectable NSCLC

oncologynews.com.au - 13/Sep 02:26

Phase 2 results from the NeoCOAST-2 study demonstrated that the combination of durvalumab with Dato-DXd yielded the highest pathological complete...

Sorry! Image not available at this time

WCLC 2024: NeoCOAST-2 Data shows combination of durvalumab with novel agents increases pathological responses in resectable NSCLC

oncologynews.com.au - 13/Sep 02:26

Phase 2 results from the NeoCOAST-2 study demonstrated that the combination of durvalumab with Dato-DXd yielded the highest pathological complete...

Sorry! Image not available at this time

Data Shows Cell-Free DNA Test Predicts Colorectal Cancer Survival

medindia.net - 00:35

A new GALAXY study reveals Signatera's cell-free DNA test predicts survival rates and chemotherapy benefits for colorectal cancer patients with high...

Les derniers communiqués